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Cold Spring Harbor Asia/International Society for
Stem Cell Research Conference; Cellular Programs
and Reprogramming (October 24e28, 2011)The Cold Spring Harbor annual meeting, “Cellular Programs
and Reprogramming”, was held at the Dushu Lake Confer-
ence Center, Suzhou, China. The meeting started with
welcoming remarks by Ronald D. McKay (National Institute
of Health, USA) followed by the opening keynote address
delivered by Elaine Fuchs (Rockefeller University, USA; Cell
Stem Cell 10, 63-75, 2012; Nat. Rev. Mol. Cell. Biol. 13, 103-
114, 2012; Cell 144, 341-352; Cell 92-105, 2011), who
summarized her research on skin stem cells and wound
repair and cancer. Using H2B-GFP pulse, chase and trace of
imaging, she described the determination of how extrinsic
signaling to stem cells sets off a cascade of changes in
transcription that governs the activation, polarization, and
migration of stem cells during tissue development,
homeostasis, hair cycling, and wound repair. She demon-
strated the cross-talk between the Wnt, BMP, and TGFb
signaling pathways of stem cells and niches during wound
repair, quiescence, and the arrest of the generation of new
tissue. In nucleus of stem cells, the expression of H3K4me3,
H3K79me2, H3K27me3, and polycomb proteins is critical for
the determination of stem cell-niche interactions.
Human stem cells
Fred Gage (The Salk Institute for Biological Studies, USA;
Nature 473, 221-225, 2011) described neural-subtype-
specific differentiation using human ESC and iPSC tech-
nology, to generate hippocampal granule neurons and their
related disease, schizophrenia. The prospero homeobox
protein 1 (Prox1) provides a useful in vitro model for
studying neurogenesis in development and disease, as well
as a human-based platform for drug screening for human
system. Gong Chen (Pennsylvania State University, USA)
established the protocol of human iPSCs that is used to
differentiate functional neuron-like astroglial cells. Action
potentials and synaptic response were detected within glial
support. Gabriella Ficz and Wolf Reik (The Babraham
Institute, Cambridge, UK; Nature 473, 398-402, 2011)1607-551X/$36
doi:10.1016/j.kjms.2012.02.021reported the roles of hydroxymethylation and TET proteins
(conversion of 5mC to 5hmC) in reprogramming and pluri-
potency in early embryos and in stem cells. 5hmC is
enriched in the euchromatin of mouse ESCs via the action of
TET1. Linzhao Chen (Johns Hopkins University, USA)
described the reprogramming method based on the ENBA1/
ori P episomal vector for cord blood and adult PBLs. Meng Li
(Imperial College London, UK) and Joan Li (University of
Queensland, Australia) reported the productions of func-
tional dopamine neurons and the maturation of ESCs and
mesenchymal stem cells (MSCs) into neonatal kidneys.
Finally, Richard Yang (MIT, USA; Cell 144, 940-954, 2011)
summarized his studies of the transcriptional networks
involved in cell-fate determination.
Control of pluripotency
Marius Wernig (Stanford University, USA; Nature 476, 220-
223, 2011; Nat. Biotechnol. 29, 892-907, 2011) reported the
direct conversion of fibroblasts to neuronal cells in vitro
(termed induced neuronal cells [iNCs]). Previously, this
author and coworkers reported that the bHLH transcription
factors Ascl1 and Mytl1, and Pou-domain transcription
factor (Brn2/4 Z Pou3f2) are critical for the induction of
iNCs and generated functional iNCs using FoxG1 and Sox2
for astrocytic differentiation. The addition of Brn 2 to iNCs
induced the tripotent iNSCs (astrocytes, neurons, and
oligodendrocytes). Wenyu Zhou and H. Ruohola-Baker
(University of Washington, USA) described the differential
roles of hypoxia-inducible factors (HIFs) in pluripotency.
Low oxygen tension (or hypoxia) facilitates stem cell
proliferation and maintenance. HIF1a is beneficial for the
induction of iPSCs and HIF2a dominantly represses reprog-
ramming via the TNF-related apoptosis-inducing ligand
(TNFSF10, TRAIL). Shuibing Chen (Weill Cornell Medical
College, USA) and Jennifer Nichols (University of Cam-
bridge, UK) reported on chemicals that maintain of hESCs
and naı¨ve pluripotency in early mammalian embryos,
Cold Spring Harbor Asia 353respectively. Yi Zhang (The University of North Carolina,
USA; Science 333, 1300-1303, 2011; Science 334, 194, 2011)
described the critical role of the TET1-3 enzymes in the
generation of 5mC, 5hmC, 5-formylcytosine (5fC), and 5-
carboxycytosine (5caC) in early embryogenesis. Alice
Chen (Stemgent Inc., USA) reported the generation of iPSCs
via the efficient delivery of mRNA. Hitoshi Niwa (RIKEN,
Japan; Nat. Cell Biol. 13, 1024-1026, 2011) reported recent
progress regarding the network of transcription factors of
Sox2 and Klf4. Sox2 transmits the signal to Tcfap2c in the
development TS and Klf4 transmits the signal to Oct4 in the
development of ESCs.Differentiation mechanisms
Rong Lu and Irving Weismann (Stanford University, USA; Nat.
Biotechnol. 29, 928-933, 2011) described the viral genetic
barcoding with high-throughput sequencing to track the
progeny of hematopoietic single cells after transplantation.
Jennifer Antonchuk (TEMCELL Technologies Inc., Canada)
reported the role of the Jmj-C-domain-containing histone
demethylase Jhdm1a/Jhdm1b in nuclear reprogramming
using vitamin C andmiR302/367. Eric Deneault (University of
Montreal, Canada) identified the 18 factors that enhance
HSC activity and niche activity. This author and co-workers
found that Sfpi1 enhanced LIF mRNA production. In osteo-
clastogenesis, Sfpi1 and Klf10 increased Tcfec and, in
osteoclast-like cells, Prdm17 induced Sfpi1 and then Tcfec
with the help of Klf10. Hongkui Deng (Peking University,
China) reported the stepwise induction of hESCs or iPSCs to
insulin-producing cells in a chemically-defined culture
system. Most of these insulin-producing cells coexpressed
beta cell-specific markers such as NKX6-1 and PDX1. The
author and co-workers also reported the signaling pathways
that regulate the maturation of pancreatic progenitor cells
(CD24-Pdx1/Sox9/HNF6/HNF1b/NKK1) into functional beta
cells and their application to STZ-induced diabetic mice or
monkeys. Deepak Srivastava (University of California, San
Francisco, USA; Cell 142, 375-386, 2010; Nat. Cell Biol., 13,
1244-1251, 2011) described the direct differentiation of
disease-specific human iPSCs using a combination of human
heart cardiac regulatory factors (GATA4/MEF2C/TBX5).
These induced cardiomyocytes were shown to differentiate
via in vivo reprogramming. Lijian Hui (Shanghai Institutes for
Biological Sciences, China; Nature 475, 386-399, 2011)
reported that mouse mesenchymal fibroblasts were induced
directly to functional hepatocyte-like (iHep) cells via
transduction of GATA4, HNF1a, and FOXa3 and inactivation
of p19Arf, and that transplanted iHep cells repopulated the
livers of fumarylacetoacetate-hydrolase-deficient Fah(-/-)
mice and rescued almost half of the recipients from death by
restoring liver functions. Fiona M. Watt (Cambridge Univer-
sity, UK; Nat. Methods, 8, 915-916, 2011; Cell 144, 577-589,
2011; Cell 148, 33-45, 2012) reported the importance of
niches to control self-renewal and differentiation using Type
I collagen-coated adhesion islands (polyacrylamide hydro-
gels, Sulfo-SANPAH cross-linkers) and prepared human arti-
ficial micro-epidermis (composed of 5e10 cells) that
captured the single stem cell or supported the self-renewal
of epidermal stem cells. Feng Ma (Institute of Blood Trans-
fusion, CAMS, China) established an efficient blood-cell-inducing system via coculture of hESCs/hiPSCs with murine
AGM and fetal liver-derived stromal cells. hESC and hiPSC
colonies grew and differentiated into mesoderm-like cells,
and then to hematopoietic progenitor cells on Days 10 to 14.
These cells were further induced to erythrocytes, mast cells
(MCs), and eosinophils, mimicking the normal development
of human erythrocytes. This author and co-workers also
reported the efficient large-scale production of erythro-
cytes, MCs, and eosinophils derived from hESCs and hiPSCs.
Cellular interactions
Linheng Li (University of Kansas Medical Center, USA; Genes
Dev. 25, 1928-1942, 2011) demonstrated that the H19
differential methylated domain (H19-DMD) region influences
hematopoietic stem cell (HSC) fate and function. Hiromitsu
Nakauchi (Institute of Medical Science, University of Tokyo,
Japan; Cell 142, 787-799, 2010; Cell 147, 1146-1158, 2011)
reported the generation of functional organs using Pdx1-/-
blastocysts and a blastocyst complementation technique.
This researcher injected wild-type rat iPSCs into mouse
Pdx1-/- blastocysts, which resulted in the competent
replacement of defective cells and the formation of
pancreas almost entirely from the injected rat iPSCs-derived
cells. Chimeric mice of Pdx1-/- genotype survived to adult-
hood without any signs of diabetes. This new technology
seems to be useful for organ supply. Toshio Suda (Keio
University, Japan; Cell Stem Cell 9, 247-261, 2011; Cell Stem
Cell 9, 298-310, 2011; Cell Stem Cell 7, 391-402, 2010)
described the glycolytic metabolism of HSCs. Normal HSCs
maintain intracellular hypoxia, stabilize HIF-1a, and
generate ATP via anaerobic metabolism. Guoping Fan
(University of California, Los Angeles, USA; Cell Stem Cell 8,
604-605, 2011) reported DNA methylation in mouse ESCs.
This author and co-workers used triple knockout (TKO) mice
for DNMT1, DNMT3a, and DNMT3b to analyze the epi-
genomics of about 3,000 genes. 5mC was reduced to 5%,
5hmC was reduced to 0.5%, CpG became <10%, cell differ-
entiation and development upregulated, and cell metabo-
lism was downregulated. Several repressed genes were
associated with H3K4me3, H3K27Kme3, and the PRC2
complex. The repressed genes were not correlated with loss
of DNA methylation; rather, they were related to changes in
the c-Myc and Jak/Stat pathways. More than 50% of the
microRNAs were also deregulated in TKO mice. Hideyuki
Okano (Keio University School of Medicine, Japan; Proc.
Natl. Acad. Sci. USA, 108, 16825-16830, 2011) reported the
transplantation of human iPSC-derived neural progenitor
cells into the spinal cord nine days after injury. These cells
differentiated into three neural lineages, without develop-
ment of teratoma or tumors. They also induced remyelina-
tion and axonal regrowth of host 5HTþserotonergic fibers
and participated in synaptogenesis with host neurons,
promoting the recovery of locomotive function.
Molecular control
Joanna Wysocka (Stanford University of School of Medicine,
USA;Nature 470, 279-283, 2010) reported enhancer elements
that induced the formation of cranial neurons from hNCC
(neural crest), among>3400 enhancer elements. This author
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development. LinHu (University of California, Berkeley, USA;
Nat. Cell Biol. 13, 1353-1360, 2011) demonstrated that miR-
34 was a novel p53 target that played an essential role in
somatic reprogramming.Both theNanogandSox2 geneswere
also putative targets of miR-34. Andrew Xiao (Yale School of
Medicine, USA) reported the role of H2A.X in replication
burden and showed that aberrant H2A.X deposition led to the
silencing of the Chr 12qF1 locus. V. Narry Kim (Seoul National
University, South Korea;Mol Cell 43, 1005-1015, 2011; Nature
475, 201-205, 2011) showed the presence of double-negative
feedback of Lin 28 and Let7 between ESCs/cancer cells and
differentiated cells. The Let 7 family of proteins is sup-
pressed by the Lin 28 proteins (via recruitment of the
terminal uridyltransferases TUT4 and TUT7) that bind to and
induce themodification of pre-Let 7. U-tail of Uri-pre-Let 7a-
1 inhibited Let 7 processing by suppressing Dicer function.
Yukiko Gotoh (University of Tokyo, Japan; Nature Rev. Neu-
rosci. 11, 377-388, 2011) reported the quiescence of neural
stem cells (NSCs), as well as the molecular studies of niche
signals andniche support ofundifferentiatedNSCs.The signal
of p57 and the asymmetric distribution of delta-like 1
contributed to this event. Gang Wang (Shanghai Institute of
Biochemistry and Cell Biology, CAS, China; Mol. Cell 45, 459-
469, 2012) reported the role of the mediator Med23 in
embryonic stem cell stemness. The deficiency of Med23 in
ESCs promoted neural differentiation via the Erk signal, BMP,
and Wnt. Shengxi Guan (New England Biolabs., USA) repor-
ted the new modification-specific restriction enzyme
PvuRts1l, which recognizes 5hmC and 5-glucosylhydrox-
ymethylcytosine (5ghmC) in double-stranded DNA and can be
used for mapping genomic 5hmC. Zhaoyu Lin (Nanjing
University, China) developed a two-phase analysis to induce
iPSCs. Sox repressed TGFb signaling, which is required for
iPSC production. Haifan Lin (Yale University of School of
Medicine, USA; Ann. Rev. Genet, 45, 447-469, 2011, Nat.
Genet. 43, 153-158, 2010) reported the role of the YB body in
piRNA biogenesis and as a gateway for Piwi expression and
transport to the nucleus. Kat Hadjantonakis (Sloan-Kettering
Institute, USA) reported the role of Sox17 in the formation of
the ECM. Ling-Ling Chen (Shanghai Institute of Biochemistry
and Cell Biology, CAS, China; Mol. Cell 35, 467-478, 2009)
reported the role of long noncoding RNAs in human ESCs.
These RNAs are uncapped and nonadenylated and appear to
depend on snoRNA at both ends for proper processing; in
addition, they are enriched in ESCs and iPSCs. Ricardo A.
Rossello (Duke University, USA) demonstrated the conserva-
tive reprogramming of cells in all model organisms. Sheng
Ding (UCSF, USA; Cell Stem Cell 9, 113-118, 2011) reported
the direct reprogramming of human adult dermal fibroblasts
(mesoderm) to functional neurons (ectoderm) using
a combination of amicroRNA (miR-124) and two transcription
factors (MYT1LandBRN2)underpreciselydefinedconditions.
Thesehuman-inducedneurons (hiNs)exhibit typical neuronal
morphology and marker gene expression, fire action poten-
tials, and produce functional synapses among each other.
Cell therapies
Lorenz Studer (Memorial Sloan-Kettering Cancer Center,
USA; Nature 480, 547-551, 2011; Cell 145, 827-830, 2011;Cell Stem Cell, 8, 695-706, 2011; Nat. Biotechnol. 29, 233-
235, 2011) discussed the efficacy of iPSCs as a treatment
for familial dysautonomia (FD, Riley-Day syndrome,
hereditary sensory and autonomic neuropathy type III),
which is a rare genetic disorder of the peripheral nervous
system. This author and co-workers demonstrated three
disease-specific phenotypes in FD-iPS-derived cells that
were partially rescued by treating cells with the plant
hormone kinetin. They also reported the directed differ-
entiation of pluripotent stem cells (PSCs) into specialized
cells, such as spinal motor neurons or midbrain dopamine
(DA) neurons. Kevin A D’Amour (ViaCyte Inc., USA) reported
an encapsulated cell therapy for the insulin-dependent
diabetes. This author and co-workers produced pancreatic
progenitors in vitro (Pro-islets), followed by trans-
plantation to sites where they act as beta cell precursors,
at the GMP level and in a large scale. This encapsulation
device enabled the survival of implanted Pro-islets, as well
as their differentiation into functioning islet cells. Tariq
Enver (University of Oxford, UK) reported the genome-wide
identification of the targets of GATA-2 (stem/progenitor),
GATA-1 (erythroid), and PU.1 (myeloid) at the single-cell
level.
At the closing keynote address, Gordon Keller (University
Health Network, Canada; Nat. Biotechnol. 29, 1011-1018,
2011; Cell Stem Cell 8, 228-240, 2011) reported the opti-
mized lineage-specific differentiation of human pluripotent
stem cells using the various signaling pathways of activin/
nodal, Wnt, BMP, FGF, and VEGF/KDR and defined the
signaling required for self-renewing and differentiation.
Conclusion
This meeting gave the impression that the field of stem cell
research is maturing very fast, with an increase in the rate
of the development of clinical applications for novel stem
cell treatments. However, for this purpose, we need addi-
tional basic knowledge on the molecular mechanisms
underlying cellular reprogramming. We feel that no
researcher analyzed the quantitative level of the interac-
tion between each signal and transcription factor and
expected more from this interesting conference. Without
quantification, it is very difficult to conclude on the
expression of transcription factors in each signaling
cascade. We still have not found the real defined factors or
networks to determine ‘stemness’ in stem cells.
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